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INTRODUCTION
The majority of the serious alloimmune hemolysis cases
are still due to RhD incompatibility, although ABO mater-
nal-fetal incompatibility is a much more commonly seen
disorder. A much smaller fraction of the patients with hemo-
lytic disease of the newborn (HDN) are due to sensitization
to Kell, Duffy, Kidd and other Rh antigens (1, 2). The admin-
istration of rhesus immunoglobulin (Ig) prophylaxis to the
RhD-negative pregnant patients has dramatically decreased
the frequency of HDN. At the same time, the proportion of
cases that has been caused by Kell, Duffy, Kidd and other
Rh antigen incompatibility has increased from the previous
estimates of 1% to 3% (3).
Among these antigen groups, the Kidd blood group sys-
tem was discovered by Allen et al. in 1951 in a mother who
had no history of transfusion, and the women had given birth
to an infant with mild hemolytic disease that was due to anti-
Jka (4). The antithetical anti-Jkb was reported by Plaut et al.
(5) in 1953. Anti Jkbcan cause hemolytic disease that is usually
a mild and has a benign prognosis (6). In contrast the authors
of this study experienced a fatal case of a newborn who exhibi-
ting severe HDN associated with anti-Jkb.
CASE REPORT
A female patient having the AB, Rh(D)-positive boodtype
was admitted for jaundice on the fourth day after being born.
The baby was born following a normal vaginal delivery by
39-yr-old mother having birth history of gravida 4, para 2.
Her body weight was 3,000 g, and her gestational age was 37
weeks and 5 days. The mother’s past history was unremark-
able. There was no history for transfusions of blood, plasma
or any blood derivatives. The first and second siblings were
treated with phototherapy due to neonatal hyperbilirubin-
emia. At the time of admission, the patient was lethargic and
exhibited high pitched crying, she had a normal Moro-reflex,
but there was decreased respond to stimulation. The labora-
tory data indicated a hemoglobin value of 11.4 mg/dL, a
reticulocyte count of 14.9% and the appearance of moderate
anisocytosis and severe polychromasia in the peripheral blood
smear. The seroanalysis showed a total bilirubin of 46.1 mg/
dL, a direct bilirubin of 1.1 mg/dL, blood urea nitrogen (BUN)
16 mg/dL, creatinine 0.5 mg/dL, sodium 143 mEq/L, potas-
sium 3.8 mEq/L, chloride 112 mEq/L and a strong positive
result (+++) on the direct Coombs test. As a result of the
identification of irregular antibody from the maternal serum,
anti-Jkb was detected by the Median Diagnostic GmbH Data-
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The Kidd blood group is clinically significant since the Jk antibodies can cause acute
and delayed transfusion reactions as well as hemolytic disease of newborn (HDN).
In general, HDN due to anti-Jk
b incompatibility is rare and it usually displays mild
clinical symptoms with a favorable prognosis. Yet, we apparently experienced the
second case of HDN due to anti-Jk
b with severe clinical symptoms and a fatal out-
come. A female patient having the AB, Rh(D)-positive boodtype was admitted for
jaundice on the fourth day after birth. At the time of admission, the patient was lethar-
gic and exhibited high pitched crying. The laboratory data indicated a hemoglobin
value of 11.4 mg/dL, a reticulocyte count of 14.9% and a total bilirubin of 46.1 mg/dL,
a direct bilirubin of 1.1 mg/dL and a strong positive result (+++) on the direct Coomb’s
test. As a result of the identification of irregular antibody from the maternal serum,
anti-Jk
b was detected, which was also found in the eluate made from infant’s blood.
Despite the aggressive treatment with exchange transfusion and intensive photother-
apy, the patient died of intractable seizure and acute renal failure on the fourth day
of admission. Therefore, pediatricians should be aware of the clinical courses of
hemolytic jaundice due to anti-Jk
b, and they should be ready to treat this disease
with active therapeutic interventions.
Key Words : Anemia, Hemolytic, Autoimmune; Erythrobastosis, Fetal; Infant, Newborn; Anti-Jk
b
Received : 18 October 2004
Accepted : 11 February 2005152 W.D. Kim, Y.H. Lee
Cyte Plus Kit (Median Diagnostic GmbH, Dudingen, Switzer-
land) (Table 1), which was also found in the eluate made
from infant’s blood.
She was treated with exchange transfusion and intensive
phototherapy for 3 days. A total bilirubin was decreased (16
mg/dL), but she had a convulsion with azotemia and elec-
trolytes imbalance; BUN 41 mg/dL, creatinine 2.2 mg/dL,
sodium 134 mEq/L, potassium 8.2 mEq/L, chloride 98 mEq/
L. The emergent peritoneal dialysis was initiated under the
diagnosis of acute renal failure. Despite the aggressive treat-
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Table 1. Results for antibody identification testing in the maternal serum and the patient’s eluate
+, positive; -, negative; M*, mother; P
�
, patient.
*Commercial panel cell series by the Median Diagnostic GmbH Data-Cyte Plus Lot No. DC-962.
Kornstad &
Halvorsen
(11)
Geczy &
Eslie
(15)
Wagman &
Bove
(16)
Zodin &
Anderson
(17)
Lange 
et al. 
(18)
Kim 
et al.
(19)
Merlob 
et al.
(20)
Tomar 
et al. 
(21)
Park 
et al. 
(22)
Present 
case
GA (weeks) 41 Full-term 37 Full-term Full-term 38 38 Full-term 37 37
Onset of jaundice (hr) 4 Early (?) 2 Early (?) NM 24 Birth 30 24 Early (?)
Day of peak T-bilirubin (day) 2 2 1 2 1 3 2 2 4 4
Peak T-bilirubin (mg/dL) 10.3 9.0 4.9 8.4 8.0 24.5 16.8 14.4 24.0 46.1
Hemoglobin (g/dL) 12.0 14.8 21.2 NM 17.0 13.1 12.4 18.8 9.7 11.4
Hematocrit (%) NM NM 61.0 60.5 NM 39 37.4 NM 28.1 36.8
Reticulocyte (%) 6.4 4.6 NM NM NM 5.8 6.7 6.0 5.0 14.9
Treatment None None None None None PT PT & TF NM PT PT & ETF
Outcome Good Good Good Good Good Good Good Good Good Fatal
Gravida-para 5-4 2-1 3-3 5-4 NM 1-0 3-3 4-3 2-1 4-2
Previous HDN siblings 2nd child None NM None NM None 2nd child None None Suspected 
1st and 2nd child
Table 2. Summary of the clinical and laboratory data from the published cases of hemolytic disease of newborn due to anti-Jk
b
GA, gestational age; NM, not mentioned; PT, phototherapy; TF, transfusion; ETF, exchange transfusion.
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ment with peritoneal dialysis and anticonvulsant therapy,
the patient died of intractable seizure and acute renal failure
on the fourth day of admission. The results of tandem mass
screening for metabolic disease revealed normal values. All
the specimen cultures showed no growth.
Consequently, the HDN was very likely due to Jkb incom-
patibility since the fetal bloodtype was AB, Rh-positive and
Jkb (+), while the mother was indicated as AB, Rh-positive
and Jkb (-).
DISCUSSION
The Kidd blood group is a major antigenic system in
human erythrocytes, and this antigen system is defined by
two antithetical specificities, Jka and Jkb, and a third rare
recessive gene, Jk, that produces neither Jka nor Jkb antigens
(7). The Kidd antigens are localized on a 43 kDa red blood
cell integral membrane protein that functions as a urea trans-
porter (8). JKA and JKB are alternate, autosomally inherit-
ed codominant alleles. The Kidd blood group is clinically
significant since Jk antibodies can cause acute and delayed
transfusion reactions as well as HDN.
Anti-Jkb was first described by Plaut et al. in 1953 (5).
Most of the reports on anti-Jkb have stated that this condi-
tion followed after repeated blood transfusions (9, 10). The
first case of anti-Jkb related HDN was reported by Kornstad
and Halvorsen in 1958 (11). Up to the present time, only
eleven cases of anti- Jkb related HDN have been reported in
the medical leterature. Although approximately 20-29% of
the Caucasian and Asian population have the phenotype
Jk(a+b-) (12-14), introduction of the Jkb antigen into such
individuals is rarely associated with clinically manifesting
disease. This is apparently due to the fact that Jkb is a poor
antigen. Table 2 summarizes the pertinent clinical and sero-
logic data concerning the cases of HDN due to anti-Jkb that
have been reported to date (15-22). In all the reported cases,
the disease was usually mild to moderate with a benign
prognosis. Although all the infants exhibited a strongly
positive direct Coombs test, any anemia was either absent
or present to only a slight degree.
An additional case of HDN that was apparently due to
anti-Jkb has been reported by Kanner (23). This case radically
differs from those reported previously in that the woman’s
third baby was ‘‘very jaundiced and anemic’’, and the baby
died at the second day after birth. No other information
about the baby was reported. This case has not been included
in Table 2 because of insufficient data. The baby in our case
was also severely affected at the time of admission and she
suffered the neurologic consequences of kernicterus. Despite
the medical management with exchange transfusion and inten-
sive phototherapy, the baby died of intractable seizure and
acute renal failure at the fourth day after admission.
The pathogenesis of HDN due to anti-Jkb is similar to
that of other antibodies. Maternal alloimmunization occurs
when a woman’s immune system is sensitized to foreign ery-
throcyte surface antigens that stimulate the production of
immunoglobulin G (IgG) antibodies. The most common
routes of maternal sensitization are via blood transfusion or
by fetomaternal hemorrhage (transplacental passage of fetal
erythrocytes), which is associated with delivery, trauma, spon-
taneous or induced abortion, ectopic pregnancy or invasive
obstetrical procedures. In the event of a pregnancy subsequent
to becoming alloimmunized, these antibodies can cross the
placenta and result in hemolysis of fetal erythrocytes and
also anemia, which in turn can lead to potentially disastrous
consequences for the fetus (24). Our case and Kanner’s cases
differ from other reported cases on the maternal history; Kan-
ner’s and our case involved the third baby. The first and sec-
ond babies had been jaundiced, yet they had never been trans-
fused with blood, plasma or any blood derivatives. There-
fore, the anti-Jkb antibody production apparently was initi-
ated at the time of pregnancy. We can suggest that both
women had three babies with HDN due to anti-Jkb.
Although HDN of anti-Jkb incompatibility is rare malady
that generally shows mild clinical symptoms and a favorable
prognosis, we experienced the second apparent case of HDN
due to anti-Jkb that had severe clinical symptoms and a fatal
outcome. Therefore, HDN due to minor blood group insta-
bility must be ruled out for all the cases of jaundice occur-
ring 24 hr after birth. Screening and quantification of irreg-
ular antibodies are required for early diagnosis as a medical
measure to prevent kernicterus through phototherapy and
exchange transfusion, and close attention should be paid for
possible delayed hemolytic anemia.
As a therapeutic measure, prenatal genotyping for Jkb of
the fetal amniotic cells should be done to identify those
high risk pregnancies with HDN that are due to anti-Jkb
incompatibility, and the genotyping can be done by allele-
specific polymerase chain reaction. An allele-specific poly-
merase chain reaction (ASPCR) assay for prenatal genotyp-
ing of the Kidd antigen system in order to identify pregnan-
cies at risk for HDN was developed. The availability of this
assay, which can accurately genotype the Kidd blood group
system, even in the presence of extensive maternal contami-
nation, provides an important tool in managing pregnancies
at risk for Kidd-related HDN (14). For the high risk fetus,
intrauterine exchange transfusion (25), serial follow up of
the serum bilirubin level and the use of erythropoietin for
anemia (26) should be considered.
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